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Abstract
Purpose The Swiss Federal Office of Public Health
demanded a nationwide HTA registry for lumbar total disc
arthroplasty (TDA), to decide about its reimbursement. The
goal of the SWISS spine registry is to generate evidence
about the safety and efficiency of lumbar TDA.
Methods Two hundred forty-eight cases treated between
3-2005 and 6-2006, who were eligible for the 5-year follow-up
were included in the study. Follow-up rates for 3–6 months, 1,
2 and 5 years were 85.9, 77.0, 44.0 and 51.2 %, respectively.
Outcome measures were back and leg pain, medication con-
sumption, quality of life, intraoperative and postoperative
complication and revision rates. Additionally, segmental
mobility, ossification, adjacent and distant segment degener-
ation were analysed at the 5-year follow-up.
Results There was a significant, clinically relevant and
lasting reduction of back (preop/postop 73/29 VAS points)
and leg pain (preop/postop VAS 55/22) and a consequently
decreased analgesics consumption and quality of life
improvement (preop/postop 0.30/0.76 EQ-5D score points)
until 5 years after surgery. The rates for intraoperative and
early postoperative complications were 4.4 and 3.2 %,
respectively. The overall complication rate during five
postoperative years was 23.4 %, and the adjacent segment
degeneration rate was 10.7 %. In 4.4 % of patients, a
revision surgery was performed. Cumulative survivorship
probability for a revision/re-intervention-free 5-year post-
operative course was 90.4 %. At the 5-year follow-up, the
average range of motion of the mobile segments (86.8 %)
was 9.7. In 43.9 % of patients, osteophytes at least
potentially affecting the range of motion were seen.
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Conclusions Lumbar TDA appeared as efficient in long-
term pain alleviation, consequent reduction of pain medi-
cation consumption and improvement of quality of life.
The procedure also appeared sufficiently safe, but surgeons
have to be aware of a list of potential adverse events. The
outcome is stable over the 5-year postoperative period. The
vast majority of treated segments remained mobile after
5 years, although almost half of patients showed
osteophytes.
Keywords SWISSspine  TDA  Disc arthroplasty 
Lumbar disc prosthesis  Long-term follow-up
Introduction
Although surgical fusion of the painful degenerated lumbar
intervertebral disc has always been a matter of debate, it
has become a gold standard procedure for all cases that
lack an alternative treatment [1]. At the end of the 1990s,
total disc arthroplasty (TDA) was introduced as a motion-
preserving treatment method. While the motion-preserving
principle of TDA is regarded as a strict antithesis of fusion,
the short-term and first long-term evidence from investi-
gation device exemption studies show mostly equivalent
outcomes after lumbar TDA and anterior lumbar interbody
fusion (ALIF) [2, 3] with some differences in favour of
TDA like, e.g., improved physical function and earlier
return to work [4–6]. The recently published 5-year follow-
up of a Swedish randomized clinical trial (RCT) with a
very high follow-up rate showed significantly better out-
comes in almost all clinical and functional outcomes for
TDA patients in comparison with posterior spinal fusion in
highly selected patients [7]. However, ALIF and not pos-
terior fusion is regarded as the most appropriate TDA
comparator. Available long-term single-arm studies are
mostly of the monocentric type and report on only one-disc
prosthesis model such as Maverick, AcroFlex, Prodisc-L or
Charite´ [8–12]. The Swedish RCT was also monocentric
[7]. Two long-term RCTs with a single disc model by
Guyer et al. [3] and by Zigler et al. [2] collected data from
multiple sites.
Long-term follow-up data are particularly expected to
answer questions of complication and revision rates,
probability of survivorship and adjacent segment degen-
eration. The data on these outcomes are still sparse and
hinder acceptance of lumbar TDA on a larger scale.
Due to increased use, reports on high complication rates,
and a general uncertainty regarding treatment outcomes, a
governmentally mandated Swiss national registry for disc
arthroplasty and some other spinal implants were estab-
lished in March 2005. Short-term outcomes of lumbar TDA
from the so-called SWISSspine registry were already
reported [13–16]. The next step in the technology assess-
ment was the analysis of the 5-year follow-up results,
which are presented in the current study.
Materials and methods
The SWISSspine registry
The detailed setup of the registry was already reported
[13]. The nationwide registry is ongoing since March 2005
and documents the following data: surgeon-based inter-
vention and follow-up forms, patient-based preoperative
comorbidity form as well as pre- and postoperative North
American Spine Society outcome assessment instrument
for the lumbar spine (NASS) and EuroQoL-5D [13].
Additionally, an informed consent form is signed by each
patient. The registry runs on the generic registry platform
MEMdoc of the Institute for Evaluative Research in
Medicine at the University of Bern [17]. Since the registry
is a governmentally mandated quality and technology
assessment project, no approval of the local ethics com-
mittees was needed.
Sample characteristics
Five-year follow-ups were initiated in 2011 and included
248 eligible patients, who were treated between March 1st
2005 and July 1st 2006. 22.8 % of those patients were
treated on two levels. 54.8 % were female. Females were
on average 41.1 years old (SD 8.4 years; range
19–65 years); the male mean age was 43.6 years (SD
7.8 years; range 20–64 years). Figure 1 demonstrates pro-
portions of different comorbidities at the time of surgery.
Fig. 1 Comorbidities (%)
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The following five devices were implanted in the con-
sidered time period and included in the current report (in
alphabetic order): Activ L, B. Braun; Charite´, DePuy;
Dynardi, Zimmer; Maverick, Medtronic; ProDisc-L,
Synthes.
The analyses focused on the 3–6 month, 1-, 2- and
5-year follow-ups. Surgeon-based follow-up rates for the
given time points were 85.9, 77.0, 44.0 and 51.2 %,
respectively. Despite trying to contact every patient for the
5-year follow-up, 48.8 % of patients were lost to follow-up
due to different reasons: unwillingness to participate
(n = 16), revision surgery on the index level (included in
the revision rate) (n = 10), patient moved away (n = 6),
surgeon moved away (n = 4), follow-up appointment
could not be set up yet (n = 2), patient death due to rea-
sons unrelated to the TDA surgery (n = 1), patient in
prison (n = 1), not specified (n = 81). Notably, 54 of 81
patients with no specified reason (54/248 = 21.8 %) were
already lost 1 year after surgery, and 67 of 81 patients were
lost 2 years after surgery (67/248 = 27.0 %).
In total, 829 follow-ups were performed during the five
postoperative years, which resulted in an average 3.3 fol-
low-ups per patient.
Outcome measures
The following outcomes were assessed:
1. Back and leg pain levels (VAS on NASS form).
2. Pain medication (based on pre- and postoperative
surgeon forms: none, NSAIDs, weak opiates, strong
opiates).
3. Quality of life [EuroQoL-5D, score ranging from -0.6
(worst possible quality of life) to 1 (best possible
quality of life)].
4. Complication and revision rates (based on peri- and
postoperative surgeon forms).
5. Heterotopic ossification (HO) [only at the 5-year time
point: (a) X-ray based surgeon assessment with an
answer for ossification yes/no, (b) X-ray based assess-
ment of an independent assessor using McAfee clas-
sification] [18]. Category 0—no HO present; category
I––HO present in islands of bone within soft tissue, but
not influencing the range of motion of the vertebral
motion segment; category II––HO possibly affecting
segmental range of motion and/or HO present between
the two planes formed by the vertebral endplates;
category III––range of motion of the vertebral end-
plates is blocked by the formation of HO and/or
postoperative osteophytes on flexion–extension or
lateral bending radiographs; category IV––HO is
causing inadvertent arthrodesis by bridging trabecular
bone between adjacent endplates and\3 of motion on
lateral flexion–extension radiographs [18]. To compare
the surgeon and independent assessors’ ratings, McA-
fee categories 0–II were grouped as no ossification and
categories III and IV as ossification.
6. Segmental mobility (only at the 5-year time point:
sagittal X-ray measurements in flexion and extension).
The involved surgeons indicated whether the treated
level was mobile (yes/no). Subsequently, an indepen-
dent assessor measured the ROM on functional X-rays.
Segments with ROM \2 were considered as immo-
bile. The data for heterotopic ossifications and seg-
mental mobility were available for 68.5 % (n = 87) of
the patients, who were examined at 5-year follow-ups
and also underwent an X-ray examination (n = 127).
7. Adjacent segment degeneration (ASD). The involved
surgeons indicated whether a progressing degeneration
of cranial, caudal or both adjacent segments as well as
of cranial, caudal or both distant segments had taken
place. The data on adjacent segment degeneration were
available for 81.1 % (n = 103) of the patients and on
distant segment degeneration for 74.8 % (n = 95) of
the patients, who were examined at 5-year follow-
up (n = 127). The missing entries were not regarded
as absence of degeneration, but excluded from the
calculations of rates.
Statistical analysis
Wilcoxon’s rank-sum test was used for comparisons
between baseline and follow-up continuous variables such
as pain on VAS. When comparing proportions, the Chi-
square test was used. Associations between follow-up
interval and proportion of different medications were tested
using the Cochran–Armitage Trend test.
Kaplan–Meier survival analysis was performed with the
first revision of any type as the end point. Patients were
censored at their last available follow-up.
a was set to 0.05 throughout the study. All statistical
analyses were conducted using SAS 9.3 (SAS Institute,
Inc., Cary, NC, USA).
Results
The average follow-up time for the 5-year follow-ups was
5.55 years (95 % confidence interval 5.46–5.64 years;
range 4.10–6.50 years).
Pain levels and medication
There was a significant (p \ 0.001) and long-lasting back
and leg pain relief from 72 and 55 points preoperative to 28
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and 22 points postoperative at the fifth postoperative year.
Thus, the average back and leg pain reliefs until year 5
were 42 and 31 points, respectively. The course of back
and leg pain is shown in Fig. 2.
The proportion of patients with no pain killer con-
sumption increased from preoperative 3.4 to 66.0 % at
5 years. Accordingly, the proportion of patients consuming
NSAIDs, weak and strong opioids decreased from 79.1,
18.4 and 23.9 % to 24.5, 6.6 and 5.7 %, respectively.
Notably, the course of consumption reduction between the
first and the fifth postoperative year had a significantly
decreasing trend for NSAIDs (p = 0.015). The trends for
weak and strong opioids were not significant (p [ 0.81).
Quality of life
The improvement of quality of life was also significant
(p \ 0.001) and long lasting. Preoperatively, the EuroQoL-
5D score was 0.30 and at the 5-year follow-up it was 0.76.
The course of postoperative quality of life is shown in
Fig. 3.
Segmental mobility and ossification
According to surgeon assessments, 79.5 % of the segments
were mobile and 13.5 % of the segments had osteophytes.
The independent assessment of functional X-ray mea-
surements showed that in 13.0 % of the segments range of
motion (ROM) was between 0 and 2. The average range
of motion of the remaining mobile segments (87.0 %) was
9.8 (range 2–25; SD 5.7), whereas in 13.0 % ROM was
between 2 and 3. In patients treated on two levels, the
caudal segments were on average 2.5 less mobile than the
cranial ones (7.8 vs. 10.3; p = 0.043). Regarding osteo-
phytes, 13.2 % of segments were classified as McAfee
grade 0, 43.0 % as grade I, 27.2 % as grade II, 16.7 % as
grade III and none as grade IV.
Complication and revision rates
Analysis of complications and revisions by treated level is
shown in Table 1.
During surgery, a total of 11 complications in 11
patients occurred (4.4 %). In particular, there were five
vessel injuries, two vertebral fractures, two dura lesions,
one subsidence of the prosthesis and one ureter lesion. The
rate of intraoperative complications was higher in biseg-
mental (7.1 %) than in monosegmental patients (3.6 %).
Postoperatively, in eight patients (3.2 %) a new radic-
ulopathy between L3 and S1 was diagnosed. The new
radiculopathy was more frequent in monosegmental
(3.6 %) than in bisegmental patients (1.8 %). In four
patients with the new radiculopathy and in six other
patients (10/248 = 4.0 %) a re-intervention was per-
formed. The re-intervention rate in bisegmental patients
(8.9 %) was higher than in monosegmental patients
Fig. 2 The course of back and
leg pain over 6.5 years with the
95 % confidence intervals. All
available follow-ups per patient
were considered
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(2.6 %). In 4 out of 10 patients who were revised, an
intraoperative complication was diagnosed. Those were the
two patients with a vertebral fracture, one dura lesion and
one subsidence of the prosthesis.
During follow-up, a new radiculopathy was diagnosed in
20 patients (8.1 %). Overall, in 26 patients (10.5 %) a new
radiculopathy was recorded either early postoperative or
during follow-ups. In three patients, a retrograde ejacula-
tion (male patient-based rate 3/113 = 2.7 %) and in seven
other patients a sympathectomy effect (2.8 %) were diag-
nosed. Forty-one other events were registered during fol-
low-up in 31 patients (patient-based rate 12.5 %) and are
shown in the Table 2.
Overall, the patient-based rate for an intra-, postopera-
tive-, and follow-up complication including new radicu-
lopathy, retrograde ejaculation and a sympathectomy effect
was 23.4 % (n = 58).
During the five postoperative years, 11 patients (4.4 %)
underwent a revision surgery or another related re-inter-
vention. Ten revisions involved monosegmental patients
(5.2 %) and one revision was performed in the caudal
segment of a bisegmental patient (1.8 %). In 10 out of 11
revised patients one or several indications for a revision
surgery were specified (Table 3): in five patients, a
spondylodesis without prosthesis removal, in three patients
prosthesis removal and spondylodesis, in one patient
wound revision, in one patient decompression, and in one
patient spondylodesis on a new caudal level were
documented. The indication for the spondylodesis on a new
caudal level was not specified. In two cases, a trauma was
specified, whereas a very good postoperative course before
the trauma was observed.
The average time to the first revision surgery was
33.4 months (range 1–79 months). A Kaplan–Meier sur-
vival analysis resulted in a cumulative survivorship of
90.4 % over 5 years (95 % CI 80.3–95.4 %) (Fig. 4).
Adjacent and distant segment degeneration
Eleven patients (11/103 = 10.7 %) developed signs of
ASD progression. Four out of 11 patients were treated on
one segment (for monosegmental patients at 5-year follow-
ups 4/78 = 5.1 %) and 7 other patients on two segments
(for bisegmental patients at 5-year follow-ups
7/25 = 28.0 %). All 11 patients had progression of the
cranial adjacent segment.
Only 2 out of 95 patients with recorded data on distal
segment degeneration had a progression of a distant seg-
ment degeneration (2/95 = 2.1 %), which was also located
cranially. One progression of degeneration was docu-
mented in a monosegmental patient (for monosegmental
patients at 5 years 1/72 = 1.4 %) and one in a bisegmental
patient (for bisegmental patients at 5 years 1/23 = 4.4 %).
One progression of distant segment degeneration occurred
in a patient with an adjacent segment degeneration, who
was a bisegmental patient.
Fig. 3 The course of EQ-5D
score-based quality of life over
6.5 years with the 95 %
confidence intervals. All
available follow-ups per patient
were considered
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Comparison of patients with and without 5-year
follow-ups
Table 4 demonstrates comparisons of different character-
istics between the two patient groups. No significant dif-
ferences were seen for patients’ demographic
characteristics. Postoperative back pain levels and quality
of life scores were slightly but significantly worse in
patients without long-term follow-ups (Table 4). These
patients also had slightly but insignificantly higher back
pain (p = 0.08) and lower quality of life (p = 0.10) at
baseline. In the end, both groups benefited from a com-
parable and insignificantly different back pain relief and
quality of life improvement. Also pre- and postoperative
leg pain and leg pain relief were similar between the
groups. There was an insignificant trend towards a higher
rate for intraoperative complications in patients without
long-term follow-ups. A significant difference in the
overall proportion of patients with a newly diagnosed
radiculopathy was seen, whereby patients with long-term
follow-ups showed an about three times higher rate. Fur-
thermore, proportions of events during follow-ups and
overall combined complication rates were significantly
higher in patients with long-term follow-up.
Table 3 Characteristics of performed revisions
No. Segment Indications/symptoms Reoperations/complications
during index surgery
Revision/re-
intervention type
Disc
implant
Spondylodesis
type
1 L5/S1 Persistent pain Radiculopathy Spondylodesis In situ Dorsal
2 L4/5 Implant dislocation, pain, facet joint
arthritis
None Spondylodesis In situ Dorsal
3 L3/4 n.s. None Spondylodesis on
a new caudal
level
– Ventral
4 L4/5 Pain after a weight lifting trauma None Spondylodesis In situ Dorsal
5 L4/5 Implant dislocation, vertebral
fracture
None Spondylodesis Removed Ventral
6 L5/S1 Wound healing disorder None Wound revision – –
7 L4/5 Implant dislocation None Spondylodesis Removed Ventral
8 L3/4 Persistent pain None Spondylodesis In situ Dorsal
9 L5/S1 Radiculopathy, retrograde
ejaculation
Dura lesion during primary
intervention, radiculopathy,
reoperation
Decompression – –
10 L5/S1 Endplate fracture with bony
fragment, implant subsidence,
radiculopathy
Radiculopathy, reoperation Spondylodesis In situ Dorsal
11 L4/
5 ? L5/
S1
Implant dislocation after a trauma None Spondylodesis Removed Ventral
n.s. not specified
Table 2 Other events which were reported during five postoperative
years
Event N
Low back pain 12
Facet syndrome 5
Displacement of prosthesis 2
ISG syndrome 3
Neurological deficits in lower extremity 3
Endplate fracture 2
New leg pain unclear etiology 2
Wound healing disorder 1
Abdominal pain 1
Intestinal disorders 1
Discopathy with internal annulus rupture 1
N. genitofemoralis irritation 1
Neuropathic foot 1
Urination problem 1
Pain irradiation in the testicles region 1
Subileus signs 1
Small abdominal hernia 1
Muscular imbalance 1
Residual disc sequester 1
2120 Eur Spine J (2014) 23:2114–2126
123
Discussion
The value of lumbar total disc arthroplasty in the variety of
spinal surgical procedures is still debated although several
studies have proven the usefulness of this procedure, its
non-inferiority or superiority to lumbar fusion in selected
patients, and its safety regarding reoperations or compli-
cations [2, 3, 6, 7]. Also, cost-effectiveness compared with
fusion was repeatedly shown [19–21]. However, evidence
about long-term outcomes is still awaited.
An RCT with 5 years follow-up of 161 TDA patients
with a Charite´ disc versus 75 patients with ALIF by Zigler
et al. [2] showed that patients treated with either method
maintained significant improvements until 5 years postop-
erative. The TDA group had significantly better improve-
ments in ODI and SF-36 at some postoperative time points.
The 2-year neurological success was also significantly
higher in the TDA group. According to the authors,
although TDA patients avoiding the stiffness of fusion and
being more satisfied than fusion patients, both fusion and
TDA were reasonable surgical options in this specific
patient population. Similarly, the RCT by Guyer et al. [3]
did not find significant differences between TDA and
ALIF, except for a statistically greater rate of part- and full-
time employment and a statistically lower rate of long-term
Fig. 4 Kaplan–Meier plot for the first revision or re-intervention of
any type within five postoperative years (maximum 2,612 days)
Table 4 Comparison of patients with and without 5-year follow-ups
Patient characteristics Patients with a
5-year follow-up
Patients without a
5-year follow-up
Comparison
(p value)
N 127 121 –
Mean age (SD) 41.6 (8.7) 42.9 (7.6) 0.21
Age range 19–65 25–62 –
Female (%) 59.8 50.0 0.10
Bisegmental patients (%) 23.6 20.7 0.57
L4/5 (%) 26.8 32.2 0.52
L5/S1 (%) 13.4 17.4
L4/5 ? L5/S1 (%) 46.5 39.7
Other treated segments (%) 13.4 10.7
Time to last available follow-up in months (SD) 64.9 (10.8) 19.9 (13.7) –
Preop back pain (SD) 70 (21) 74 (20) 0.08
Back pain at last available follow-up (SD) 29 (28) 39 (30) 0.011
Back pain relief (SD) 41 (32) 35 (34) 0.19
Preop leg pain (SD) 53 (28) 57 (29) 0.20
Leg pain at last available follow-up (SD) 23 (29) 25 (28) 0.36
Leg pain relief (SD) 30 (35) 32 (35) 0.84
Preop EuroQoL-5D score (SD) 0.31 (0.34) 0.25 (0.32) 0.10
EuroQoL-5D score at last available follow-up (SD) 0.77 (0.27) 0.64 (0.33) \0.001
EuroQoL-5D score improvement (SD) 0.46 (0.37) 0.39 (0.41) 0.19
Intraoperative complications (%) 2.4 6.6 0.10
Overall proportion of newly diagnosed radiculopathy (%) 15.8 5.0 0.006
Events during follow-ups (patient-based %) 16.5 8.3 0.049
Overall rate of patients with intra- or postoperative complication, or new
radiculopathy, or retrograde ejaculation, or sympathectomy, or follow-up events
30.7 18.2 0.022
All categorical characteristics were compared using the Chi-square test and all continuous characteristics using the Wilcoxon rank-sum test
SD standard deviation
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disability in TDA patients. A recent RCT of TDA versus
posterior and posterolateral fusion techniques with highly
selected patients showed significantly better results for
most of the outcomes in favour of TDA patients [7].
However, posterior fusion is a less suitable comparator for
TDA.
Pain relief, medication consumption and quality of life
In the report by Van de Kelft et al. [8] of 50 consecutive
cases with the Maverick disc, back pain levels dropped
from 7.4 preoperatively to 2.6 at the 4-year follow-up.
Blondel et al. [12] reported back pain relief from 7.2 to 2.4
and leg pain relief from 6.4 to 2.2 between baseline and
2-year follow-up in 221 patients with the ProDisc-L disc.
In the RCT by Guyer et al. [3], preoperative back pain was
about 70 VAS points and postoperative back pain was long
lasting at 30 points until 5 years postoperative. The clinical
outcome series by Park et al. of patients with ProDisc-L
showed pain relief from 7.8 preoperative to 2.3 postoper-
ative at the 5-year follow-up. The RCT by Zigler et al. on
patients with a Charite´ disc reported pain relief from 74.9
to 40 VAS points at 5 years after surgery. All these reports
are well corresponding with the pain relief observed in the
SWISSspine registry, which was 72 VAS points at baseline
and 28 points at the 5-year follow-up. Both back and leg
pain alleviation seem to last without notable deterioration
until the fifth postoperative year. This effect was reflected
in significantly reduced pain killer consumption and sig-
nificantly improved quality of life. Moreover, the quality of
life was further improving over the postoperative period, as
was the consumption of NSAIDs.
Adjacent and distant segment degeneration
In the RCT by Zigler et al. [22], 9.2 % of the TDA
patients and 28.6 % of the fusion patients showed
degenerative changes in the adjacent segments. Fused
patients had a three times higher likelihood to have an
ASD change. It is noteworthy, however, that only 76.4 %
of the TDA patients and 57.3 % of the fusion patients had
complete 5-year radiographic follow-up data. The authors
also reported that 1.9 % of the TDA group and 4.0 % of
the circumferential fusion group had adjacent-level sur-
gery during the follow-up period, which was not signifi-
cantly different [22]. David [10] reported an adjacent
level surgery in 2.8 % after 10 years in 106 patients with
Charite´ discs. We observed 10.7 % adjacent and 2.1 %
distant segment degeneration. Both adjacent and distant
segment degenerations in our cohort occurred only in
cranial segments. Our ASD proportion corresponds to the
results reported by Zigler et al. [2]. None of the indica-
tions for revision surgery in our cohort was based on
ASD, which some authors would therefore only consider
as adjacent segment degeneration, but not as true ‘‘dis-
ease’’. However, for one revision on a new caudal level
the indication was not specified.
Segmental mobility and ossification
The ROM after TDA using Charite´ discs remained roughly
constant between the 2-year (7.7) and 5-year (7.2) time
points in the RCT by Zigler et al. [2]. In their report,
91.9 % of the TDA patients had preserved a normal seg-
mental ROM at 5 years. The report by Gornet et al. [4] of
patients with Maverick discs showed an average ROM of
9.4 at 1 year and 9.5 at 2 years postoperative. Van der
Kelft et al. [8] studied 4-year results of Maverick discs and
reported average ROM between 11 and 13 on L4/5 and
L5/S1 segments, respectively. Two patients treated on the
L3/4 segment had an average 23 ROM. In the RCT by
Berg et al. [23], 88.5 % of segments treated with Maverick,
ProDisc-L or Charite´ were mobile at the 2-year follow-up.
The authors had regarded a L3/4 and L4/5 segmental ROM
of B2 as immobile (44.8 % of the studied segments), and
for L5/S1 a ROM of B4.5 for L5/S1 segment (55.2 % of
the studied segments). Guyer et al. [3] reported 84.5 % of
lumbar TDA cases with the Charite´ disc having ROM[3
at the 5-year follow-up. According to our observations
87.0 % of discs had a ROM C2, and 74.0 % a ROM [3
at 5 years. The average ROM of the mobile segments was
9.8, which is rather in accordance with the published
numbers.
The evidence about HO after lumbar TDA is sparse.
According to the 5-year results of Guyer et al. [3], 18.9 %
of Charite´ discs had HOs that would impact motion. The
authors used a six-point scale as a combined classification
system adapted from Nathan and McAfee. 16.7 % of our
segments had McAfee grade III HO defined as blocking the
range of motion of the vertebral endplates. Additionally,
27.2 % of segments were classified as grade II with a
potentially affected motion. Other authors reported much
lower ossification rates at different postoperative time
points; however, classifications other than McAfee were
used [10, 24–26]. Influence of HO on clinical outcome was
not yet confirmed in any of the reports.
The surgeon-based 13.5 % rate of osteophytes was
comparable with the independently assessed 16.7 % of
grade III HO in the current cohort.
A poor correlation between clinical outcome and posi-
tion of the prosthesis was recently reported by Boss et al.
[27] in his cohort with 2-year follow-ups from the
SWISSspine registry. Most of the patients reached a very
good clinical outcome. However, suboptimally placed
devices appear to cause significantly more neurological
symptoms [27].
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Complications and revisions
Overall observed complication and event rate was 24.6 %
during the first five postoperative years, which is a rather
high patient-based rate. However, one should note that
many observed complications and events were of a tran-
sient character reported only once during multiple follow-
ups such as low back pain or abdominal pain, muscular
imbalance and new leg pain of unclear etiology. A recent
meta-analysis of TDA versus any other intervention by
Wei et al. [28] counted major complications such as
device failures necessitating reoperations, revisions, rem-
ovals, major vessel injury, neurologic damage, nerve root
injury, death, etc., and reported a 5.8 % pooled compli-
cation rate for five trials and 1,525 patients. Many com-
plications, which were registered during follow-ups in
SWISSspine, such as vessel injury, dura lesion, urination
problem, ureter lesion, subileus signs, abdominal hernia,
abdominal pain, wound healing disorder or intestinal
disorders can be related to the surgical approach, which is
in fact the standard anterior approach to the lumbar spine.
The potentially implant-related complications were two
intraoperative vertebral fractures, one intraoperative
implant subsidence and two endplate fractures during
follow-up without surgical consequences. Moreover,
newly diagnosed radiculopathy in 10.5 % and neurologi-
cal deficits are also rather TDA-related complications.
Newly diagnosed radiculopathy was transient in 6.1 % of
the patients, but remained present in another 4.4 % at the
last available follow-up. It seems that radicular pain was
intermittent in those patients. Published figures on new
radiculopathy are rare, unfortunately. Van Ooij et al. [29]
described new radiculopathy as a late complication in
3.7 % of his 27 patients with an average of 4.4 years of
follow-up. In his retrospective analysis, McAffe et al. [30]
described 589 discs with a 2.4 % rate for iatrogenic
neurologic complications at a minimum 2-year follow-up.
In his report of the long-term results of a single surgeon
experience in the SWISSspine registry, Markwalder et al.
[31] reported one new radiculopathy in 14 studied TDA
patients (7.1 %), which was transient during 6.5 postop-
erative years. In the analysis by Boss et al. [27], which
included 46 patients, neurological radicular deficits dis-
appeared in 72.7 %, improved in 9.1 %, but remained
unchanged in 18.2 % after 2 years. The potential source
of persisting or new radiculopathy may be a recurrent disc
herniation with a sequestered fragment of the annulus,
and an incomplete disc removal [12, 29]. Furthermore, a
restoration of disc height may potentially cause increased
traction of nerve roots with or without vascular changes
that can be similar to an arterial ischemia [12]. Accord-
ingly, in the randomized controlled trial by Gornet et al.
[4] 48 % (n = 11) of the reoperations after TDA were
decompression procedures to relieve persistent postoper-
ative radicular symptoms.
The overall rate for revisions in the registry was 4.4 %.
A similar rate of 5.2 % after lumbar TDA was reported in
the meta-analysis by Wei et al. [28]. In the US, studies by
Zigler et al. [2, 30] and McAfee et al. [30] reported 8.0 and
8.8 % revision rates, respectively. If calculating our revi-
sion rate based on patients with 5-year results and patients
with known revision data, we find an 8.0 % rate.
Ross et al. [32] reported a cumulative survival rate of
90 % at 8.4 years in 160 patients with a Charite´ disc when
implant removal was the end point of the analysis. This rate
seems to be quite close to our 90.4 % at 5 years. McAfee
et al. [30] reported an even higher survival rate of 97 %
after 5 years for the Charite´ disc in 98 consecutive cases.
Further long-term surveillance of TDA revisions is cer-
tainly required and should ideally be conducted in national
registries such as SWISSspine.
Regarding mode of failure, four implant dislocations
were seen in 11 revised patients, which should be regarded
as an implant-related failure. Persistent or new back pain in
three patients, radiculopathy in two patients, vertebral
fracture in two patients and wound healing disorder in one
patient were seen otherwise. Those complications are
known revision causes after lumbar TDA [33]. During
spondylodesis revision surgery, the artificial disc was
removed in three cases and remained in situ in five cases.
McAfee et al. [30] reported similar rates for implant
removal and non-removal in their 52 revision surgeries
with a slightly higher tendency of leaving implants in situ.
In his meta-analysis, Wei et al. [28] showed TDA to be
safe and effective and suggested adopting the therapy on a
large scale.
The numbers of individual types of complications had
relatively low statistical power after stratification by treated
segment; however, in a descriptive analysis a trend for
increasing incidence of overall adverse events from a
monosegmental L5/S1 (22.4 %) over monosegmental L4/5
(30.1 %) to a bisegmental L4–S1 (39.5 %) surgery
becomes noticeable. A similar trend was also observed for
early postoperative re-intervention and sympathectomy
effect. The vascular injuries were all found in mono- and
bi-segmental cases involving L4/5 [34]. Similarly, all ret-
rograde ejaculations occurred in mono- and bi-segmental
cases involving L5/S1, which was also reported by Lindley
et al. [35].
Revision rates were relatively more frequent on L3/4,
followed by L4/5, L5/S1 and then by bisegmental surgery
on L4–S1. One of the two patients with a revision of the
L3/4 segment underwent a spondylodesis on a new caudal
level as revision surgery. The anatomical characteristics of
the two most distal lumbar segments, proximity of the
bifurcation of vessels and other anatomical structures and
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at the same time the highest load on the prosthesis are
likely explanations for these findings.
Mayer and Siepe [36] compared the history of fusion and
TDA and criticized the fact that despite a long acceptance for
fusion as the gold standard without comparative and con-
trolled evidence, despite high reoperation and complications
rates and adjacent segment alterations, no reconsideration of
this therapeutic option has taken place. A possible reason
may be the fact that for many years, fusion was the only
option surgeons had for the treatment of degenerative low
back pain. However, the worldwide introduction of lumbar
TDA since the end of the 1990s has produced paradoxical,
controversial, and occasionally irrational reactions amongst
surgeons, regulatory institutions, health insurance compa-
nies, and other health care providers [36].
Limitations and strengths
Some limitations of the study require mention. No direct
comparator was included in the SWISSspine registry; thus,
a comparative evidence judgment can only be made by
comparing the results to the published literature or other
indirect comparators [16]. A complete documentation of a
comparator procedure like fusion or non-surgical treatment
in a national registry would need additional and substantial
administrative and financial efforts, which were considered
as not feasible by the stakeholders of the registry. A
strength of the registry cohort, however, is the generaliz-
ability of its outcomes since it represents real-life clinical
practice with high external validity, at least on a national
level. The few currently existing spine registries are
expected to deliver further generalizable results on spinal
treatments [37–39]. A strength of this particular report is
that it presents both survival, radiological and clinical data.
Being an observational unmonitored study, a potential
underreporting of surgeon-based parameters such as com-
plications and revisions cannot be completely excluded. All
surgeons participating in the documentation are certified by
the Swiss Spine Society for conducting lumbar TDA sur-
gery, which means that they have proven the essential
training and qualifications and have agreed to accurately
document the interventions. The accordance between the
surgeon-based and independent measurements of ROM and
HO shows, however, at least a conscientious documenta-
tion of segmental mobility and heterotopic ossifications.
An audit or any other control mechanism in a national
registry would need strong financial and organizational
resources and was considered as not feasible by the
SWISSspine stakeholders. This remains a limitation for the
findings from the SWISSspine registry.
The 5-year follow-up rate in the analysis was 51.2 %.
The follow-up rates in long-term clinical studies in the US
vary from 43.4 % in the Guyer 2009 study of the Charite´
disc [3], to 68.3 % in the Weinstein 2009 fusion/SPORT
study [40] and 81.8 % in the RCT comparison of TDA
versus fusion by Zigler et al. [2]. The execution of the
5-year follow-ups in a national registry is, however, a
complex endeavour. Several administrative patient and
surgeon related difficulties were already reported for the
cervical cohort [38]. The registry patients who were lost to
follow-up may have potentially introduced a selection bias.
Comparison of patients with and without 5-year follow-ups
showed that the patient groups were not significantly dif-
ferent regarding patient demographics, pain relief and
quality of life improvement, but different regarding the
levels of back pain and of quality of life at the last available
follow-up. Patients lost to the 5-year follow-up had slightly
but significantly higher postoperative back pain and lower
QoL levels. One has to note, however, that the patients lost
to follow-up underwent surgery with worse baseline values
for these outcomes. The worse baseline values in patients
without long-term follow-ups and comparable pain relief
and quality of life improvement in both patient groups
reduce the meaning of the significantly different postop-
erative back pain and quality of life levels as a pro-selec-
tion bias argument. Furthermore, quality of life tends to
further improve over time as shown in Fig. 3. The average
64.9- and 19.9-month follow-up intervals in the groups
with and without 5-year follow-up may at least partially
explain the difference in quality of life levels. On the other
hand, new postoperative radiculopathy and other undesired
events were significantly higher in the group with 5 years
follow-up, which may at least partially be a function of
time. Given these facts, a clear evidence for selection bias
does not become obvious, but the follow-up rate certainly
makes it possible and may have introduced slightly
advantageous results in favour of TDA.
The overall results of our study still seem to be in
accordance with the published literature and with the short-
term results in the registry. Ten-year follow-ups of the
same cohort are planned in the near future. Furthermore,
only 68.5 % of patients underwent a radiological exami-
nation at 5 years. Patients were reluctant to undertake
radiological examinations mostly due to the out-of-pocket
expenses, if a deductible is part of the insurance contract,
which is very common in Switzerland. In addition, freedom
of symptoms makes patients accept the radiographic part of
the follow-up even less.
The studied registry cohort represents the first 248
patients, which were documented since the registry launch
and termination of the moratorium for TDA in Switzerland.
It can be speculated that further technical and instrumental
developments and continuously growing knowledge on
appropriate patient selection [41–43] should further
improve todays’ reported outcomes, but also increase
patients’ treatment expectations.
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The model of a governmentally mandated nationwide
spine registry could, if adopted in a quality controlled and
monitored way, not only provide evidence-based informa-
tion with a sufficient internal and a high external validity; it
could also generate new knowledge much faster and in a
more cost-efficient manner compared with the currently
non-harmonized individual efforts in clinical study settings,
HTAs, post-market surveillance programs, etc. The same
(registry based) dataset could be used for various purposes
and stakeholders, and they could all jointly participate in
organizing, administering and financing such an endeavor.
The ‘‘platinum version’’ of such a model would then be the
expansion into an international registry or at least a registry
cooperation, similar to Eurospine’s Spine Tango [37] or
European Federation of National Associations of Ortho-
paedics and Traumatology (EFORT) and International
Society of Arthroplasty Registries (ISAR).
Conclusions
Five-year follow-up results of lumbar TDA in the SWISSspine
registry demonstrated significant and long-lasting back and leg
pain relief along with reduction of pain killer consumption and
improvement of quality of life. The vast majority of segments
remained mobile, although 43.9 % of them showed hetero-
topic ossifications, which could at least potentially affect
segmental motion. The procedure appeared sufficiently safe,
though surgeons have to be aware of a list of potential adverse
events. Long-term observation of revision rates and adjacent
segment disease is required for further evidence generation.
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